← Web3 레이더

Tharimmune

Digital Asset Treasury https://tharimmune.com

Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.

지표 추이 (최근 90일, RD 인기지수)

추이 데이터가 아직 부족합니다.

Post-IPO

리드 투자

$540,000,000

DRW Venture CapitalLiberty City VenturesKrakenPolychain

2025-11-04

Source from RootData